<DOC>
	<DOCNO>NCT01330953</DOCNO>
	<brief_summary>The purpose study ( 1 ) To determine safety LY2928057 healthy people , side effect might associate ; ( 2 ) To understand body healthy people handle LY2928057 ; ( 3 ) To determine effect LY2928057 blood iron level people 's body ; ( 4 ) To evaluate people 's immune system react LY2928057 .</brief_summary>
	<brief_title>A First Human Study Ferroportin Antibody</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<criteria>Must either healthy male ( willing use reliable method birth control study 3 month follow last dose study drug ) , healthy female become pregnant Must body mass index ( BMI ) 18.5 32.0 kg/mÂ² , inclusive minimum body weight 55 kg Blood urine laboratory test result must acceptable study The vein must suitable easy blood collection study drug administration Must reliable willing available duration study willing follow study procedure Must give write informed consent Blood pressure pulse rate must acceptable study Blood test show subject anemia due lack iron Currently take part another clinical study complete one less 30 day ago Allergic biologic agent Have previously take part study Have abnormal electrocardiogram ( ECG ) finding suggest increase risk associate participate study Have history significant disease may affect action drug may pose risk take study medication Have history drug alcohol abuse Are infect human immunodeficiency virus ( HIV ) Have hepatitis B Are pregnant breast feed Intend use overthecounter prescription medication within 14 day prior dose , oestrogen/progesterone hormone replacement therapy ( HRT ) . Subjects take medication chronic , stable dos . Certain medication , example vitamin supplement , may permit discretion investigator . Have donate 450 mL blood within last 3 month Have regular alcohol intake great 21 units/week ( male ) , 14 units/week ( female ) , unwilling stop alcohol require study ( 1 unit = 360 mL beer , 150 mL wine , 45 mL spirit ) Are smoker ( smoke 10 cigarette per day ) use equivalent tobacco product . Subjects allow smoke study unit . Have receive live vaccine ( ) within 1 month screening , intend study Have receive treatment biologic agent ( monoclonal antibody ) within 3 month 5 halflives ( whichever longer ) prior receive study drug study Have history atopy , significant allergy humanize monoclonal antibody , clinically significant multiple severe drug allergy , intolerance topical corticosteroid , severe post treatment hypersensitivity reaction ( include , limited , erythema multiforme major , linear IgA dermatosis , toxic epidermal necrolysis , exfoliative dermatitis ) Have active mental health illness The study doctor think subject participate reason</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Anemia</keyword>
</DOC>